A detailed history of N Verses Capital, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 700 shares of TARS stock, worth $32,759. This represents 0.01% of its overall portfolio holdings.

Number of Shares
700
Holding current value
$32,759
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$21.54 - $34.6 $15,078 - $24,220
700 New
700 $23 Million
Q1 2024

Apr 25, 2024

BUY
$19.61 - $39.22 $37,259 - $74,518
1,900 New
1,900 $69.1 Million

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.25B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.